Implementing a Guideline-based Model of Care for Hip and Knee Osteoarthritis in Finland. A Benchmarking-controlled Trial (FIN-OA)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Implementation of a guideline-based model of care for hip and knee osteoarthritis.
- Who it may be relevant to
- Registry conditions: Osteoarthritis of the Hip or Knee. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This project aims to bridge the gap between guideline recommendations and clinical practice in osteoarthritis (OA) management. By implementing a systematic, evidence-based model of care, the project seeks to improve patient outcomes, reduce healthcare costs, and provide equitable access to care. The project consists of three phases. In the first phase the current OA care is mapped through registry review and questionnaires and interviews of patients and healthcare professionals. In the second, implementation phase of the project, a plan will be created how to support healthcare professionals in delivering care according to the new model of care and training and support will be offered according to the plan. In the third phase of the project, the implementation success will be evaluated, and the costs of OA care evaluated and compared to baseline data. In addition, patient-reported data will be collected from those patients, who participate in the group-based exercise and education program.
Detailed description
Osteoarthritis (OA) is a growing global health challenge, due to the significant increase in prevalence of knee and hip OA. In Finland, OA care costs are substantial, driven by diagnostic procedures, medical treatments, and indirect costs such as work absenteeism. The international guidelines recommend education, exercise, and weight management as first-line treatment options, but adherence to guidelines is inconsistent. This project aims to explore regional differences in OA care and beliefs and OA care practices in Finland. In addition, we will implement and evaluate a guideline-based model of care for hip and knee OA, that includes the Good Life with osteoarthritis from Denmark (GLA:D®) program as the preferred non-surgical management option in local care pathways. In addition, the aim is to share evidence-based OA knowledge and management skills nationwide.
This study is a hybrid type-3 benchmarking-controlled implementation trial. It is nested in primary healthcare in two Wellbeing Services Counties. The study includes three phases: pre-implementation, implementation, and evaluation. The pre-implementation activities include mapping the current OA care through registry review (healthcare utilization and costs from 2019-2024). In addition questionnaires and interviews of patients and healthcare professionals (beliefs and practices) will be conducted. Planned activities of the implementation phase include developing and integrating a new model of care (including GLA:D®) into local care pathways, and training physiotherapists to deliver it. Implementation theories and multifaceted implementation strategies will be used and adapted locally. The activities to evaluate the process include assessment of the implementation outcomes on healthcare professional and organizational levels, healthcare resource utilization and cost outcomes (1, 3 and 5 years) using registry data. In addition outcomes reported by patients participating in the GLA:D program will be collected at 3 months and 1, 3 and 10 years.
This project aims to bridge the gap between guideline-recommended OA-management and clinical practice. By implementing a systematic, evidence-based model of care, the study seeks to improve patient outcomes, reduce healthcare costs, and provide equitable access to care. The findings will inform future OA care strategies and will be disseminated and adapted to other healthcare contexts in Finland and can be adapted also internationally. The findings will be published in peer-reviewed journals and presented in national and international conferences.
Interventions
- Behavioral Implementation of a guideline-based model of care for hip and knee osteoarthritis
Guideline-based model of care including GLA:D (Good Life with osteoArthritis from Denmark) -program that includes training for physiotherapists and group based education and exercise for patients with hip and knee OA.
Primary outcome measures
- Cost of OA care [Time frame: 1 (primary endpoint), 3 and 5 years after implementation compared to baseline 2018-2024]
- Reach: Proportion of patients directed according to the model of care [Time frame: 1 (primary endpoint) 3 and 5 years after implementation]
Secondary outcome measures (12)
- Number of trained GLA:D trainers and physiotherapists [Time frame: 1, 3 and 5 years after implementation]
- Participation of patients in GLA:D program [Time frame: 1, 3 and 5 years after implementation]
- Pain intensity during last week, numerical rating scale [Time frame: Baseline, 3 months, 1, 3 and 10 years]
- Problems walking due to knee /hip [Time frame: Baseline, 3 months, 1, 3 and 10 years]
- UCLA activity score [Time frame: Baseline, 3 months, 1, 3 and 10 years]
- Fear of movement [Time frame: Baseline, 3 months, 1, 3 and 10 years]
- Use of painkillers [Time frame: Baseline, 3 months, 1, 3 and 10 years]
- Current employment [Time frame: Baseline, 3 months, 1, 3 and 10 years]
- Sick leave because of knee / hip during last year [Time frame: Baseline, 3 months, 1, 3 and 10 years]
- EQ-5D-5L [Time frame: Baseline, 3 months, 1, 3 and 10 years]
- K/HOOS-12 [Time frame: Baseline, 3 months, 1, 3 and 10 years]
- Global perceived effect [Time frame: 3 months, 1, 3 and 10 years]
Eligibility criteria
Data from national registries:
- Patients with diagnosed OA (ICD-10 / ICPC2)
- age over 18 years
Collection of GLA:D patient-reported outcomes:
Inclusion criteria
- Patients who are participating in theGLA:D program, diagnosed with hip or knee osteoarthritis, fluent in finnish
- age over 18 years
Exclusion criteria
- Other than OA-related cause of symptoms
- not able to answer the questionnaires in Finnish
- no access to a computer or mobile device to answer the questionnaires
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06904885 · 263/13.00.04.00/2025